scholarly journals Intravenous infusion of mesenchymal stem cells promotes functional recovery in a rat model of chronic cerebral infarction

2019 ◽  
Vol 131 (4) ◽  
pp. 1289-1296 ◽  
Author(s):  
Takahiro Namioka ◽  
Ai Namioka ◽  
Masanori Sasaki ◽  
Yuko Kataoka-Sasaki ◽  
Shinichi Oka ◽  
...  

OBJECTIVEIntravenous infusion of mesenchymal stem cells (MSCs) derived from adult bone marrow improves behavioral function in rat models of cerebral infarction. Although clinical studies are ongoing, most studies have focused on the acute or subacute phase of stroke. In the present study, MSCs derived from bone marrow of rats were intravenously infused 8 weeks after the induction of a middle cerebral artery occlusion (MCAO) to investigate whether delayed systemic injection of MSCs improves functional outcome in the chronic phase of stroke in rats.METHODSEight weeks after induction of the MCAO, the rats were randomized and intravenously infused with either MSCs or vehicle. Ischemic volume and behavioral performance were examined. Blood-brain barrier (BBB) integrity was assessed by quantifying the leakage of Evans blue into the brain parenchyma after intravenous infusion. Immunohistochemical analysis was also performed to evaluate the stability of the BBB.RESULTSMotor recovery was better in the MSC-treated group than in the vehicle-treated group, with rapid improvement (evident at 1 week post-infusion). In MSC-treated rats, reduced BBB leakage and increased microvasculature/repair and neovascularization were observed.CONCLUSIONSThese results indicate that the systemic infusion of MSCs results in functional improvement, which is associated with structural changes in the chronic phase of cerebral infarction, including in the stabilization of the BBB.

Author(s):  
N. Lozano-Rivas ◽  
L.F. Linares ◽  
C. Marras-Fernandez-Cid ◽  
A.M. Garcia-Hernandez ◽  
M.D.C. Algueró ◽  
...  

2015 ◽  
Vol 2015 ◽  
pp. 1-8 ◽  
Author(s):  
Lihong Fan ◽  
Ruiyu Liu ◽  
Jia Li ◽  
Zhibin Shi ◽  
Xiaoqian Dang ◽  
...  

Objective.Glucocorticoids can affect the function of bone marrow-derived mesenchymal stem cells (BMMSCs) adversely and merit the requirement for a strategy to correct this anomaly; we assessed the effect of low oxygen (2%) on BMMSCs from rabbits with osteonecrosis.Methods.Bone marrow-derived mesenchymal stem cells from normal rabbits and rabbits with osteonecrosis were divided into four groups: (1) normal-normoxia group, with normal BMMSCs cultured under 20% oxygen; (2) osteonecrosis-normoxia group, with BMMSCs from rabbits with osteonecrosis cultured under 20% oxygen; (3) osteonecrosis-low oxygen treated group, with BMMSCs from rabbits with osteonecrosis cultured under 2% oxygen; (4) normal-low oxygen treated group, with normal BMMSCs cultured under 2% oxygen. The proliferation, osteogenic, and adipogenic differentiation of MSCs and expression of stemness genes, osteogenic, and adipogenic differentiation markers were investigated.Results.Compared with BMMSCs from normal rabbits, those from osteonecrosis rabbits showed significantly reduced proliferation ability, repressed expression of stemness genes, decreased osteoblasts formation, and increased adipocytes formation, indicating an osteonecrosis-related impairment. Low oxygen (2%) treated BMMSCs from osteonecrosis rabbits showed not only increased proliferation and osteogenic potential but also decreased adipogenic potential.Conclusion.Low oxygen (2%) culture represents a novel strategy to augment BMMSC function affected by glucocorticoids and holds significance for future strategies to treat femoral head osteonecrosis.


Blood ◽  
2006 ◽  
Vol 108 (11) ◽  
pp. 2576-2576
Author(s):  
Gexiu Liu ◽  
Guangxiao Tan ◽  
Yanhui Wu

Abstract INTRODUCTION: Transplantation of autologous bone marrow mesenchymal stem cells (MSCs) is increasingly being considered in cell-based therapeutic strategies for traumatic brains. Pluripotent MSCs can differentiate into neural cells, but few reports completely address the therapeutic effect of transplanting the cells into damaged brains in vivo. The early remarkable functional effect of MSC-transplantation cannot be readily attributed to tissue regeneration from MSCs. Hypoxia is the major characteristic of ischemic microenvironment. Low oxygen tension is thought to be an integral component of the MSC native bone marrow microenvironment. Thus, we hypothesized that paracrine actions exerted by the cells through the release of soluble factors might be partly important mechanisms of tissue repair and functional improvement after injection of MSCs. In the current study, we demonstrate that hypoxia induces expression of vascular endothelial growth factor (VEGF) in rat bone marrow MSCs, and VEGF markedly inhibits apoptosis of neonatal rat neurons induced by hypoxia in vitro. METHODS: Adult Sprague-Dawley rat bone marrow MSCs and neonatal rat neurons were purified and cultured. MSCs were characterized by high expression of CD44, the lack of CD45 and CD11b molecules, their typical spindle-shaped morphology, together with their ability to differentiate into osteogenic, chondrogenic, and adipogenic cells, and neurons by expression of neuron specific enolase and neuronal nuclei marker NeuN. In the experiments, MSCs were co-cultured with or without neurons at the density of 2×105 cells/ml (ratio of 1:1) in DMEM/F12 containing 15% FBS. After 24 hours, cells were cultured with hypoxic DMEM/F12 containing 5% FBS in hypoxia condition (93% N2 + 2% O2 +5% CO2), and were treated with or without 0.2 nM VEGF and/or 100 nM SiRNA specific for VEGF mRNA. 72 hours after hypoxic culture, cells were harvested for analysis of cell apoptosis by flow cytometry. Level of the VEGF protein in medium was detected by ELISA. RESULTS: The apoptotic ratio of normoxic cultured neurons was (11.46±2.68)% at 72 hours. The apoptotic ratio of hypoxic cultured neurons increased to (38.95±4.23)% (P<0.01). The apoptotic ratio of neurons co-cultured with MSCs in hypoxic condition decreased to (17.52±3.19)% (P<0.01). VEGF protein in the co-cultured media was (178.15±11.93) pg/ml, which were undetectable in media of normoxic or hypoxic cultured neurons. However, specific SiRNA enhanced the apoptotic ratio of hypoxic-induced neurons co-cultured with MSCs (30.81±4.09)%, and inhibited expression of VEGF protein in MSCs. Moreover, 0.2 nM VEGF reversed the role of specific SiRNA, of which the apoptotic ratio was (16.83±3.16)% (P<0.01). CONCLUSION: These results showed that hypoxia induced expression of VEGF in bone marrow MSCs, and co-culture with MSCs improved the viability of neurons in hypoxia condition in vitro. We conclude that VEGF is involved in protective effects of Mesenchymal stem cells on cultured neurons in hypoxic condition. These evidences support paracrine hypothesis for mesenchymal stem cell-mediated acute neuroprotective effect and functional improvement, and the paracrine action is one of the multiple mechanisms of MSCs-based therapy for traumatic brains.


2018 ◽  
Vol 22 (5) ◽  
pp. 513-522 ◽  
Author(s):  
Takuro Sakai ◽  
Masanori Sasaki ◽  
Yuko Kataoka-Sasaki ◽  
Shinichi Oka ◽  
Masahito Nakazaki ◽  
...  

OBJECTIVEChildren who have experienced neonatal hypoxic-ischemic encephalopathy often develop cerebral palsy. Although many treatments have been performed, few effective therapies are available. In this study, the authors tested in rats with hypoxia-ischemia (HI) injuries the hypothesis that the systemic infusion of mesenchymal stem cells (MSCs) would result in functional improvement by facilitating neural compensation in the contralesional cortex.METHODSPostnatal day (P) 7 (P7) rats that had undergone unilateral hemisphere hypoxia-ischemia (modified Rice-Vannucci model) were randomly assigned to MSC-infused or vehicle-infused groups. MSCs (1.0 × 106/200 μL) or vehicle were intravenously infused on P10. Brain volume was measured using in vivo MRI on P8 and P35. On P35, the rats were sacrificed after their behavior was evaluated using a beam walk test, and their brains were then prepared for histological analyses.RESULTSThe MSC-treated group had fewer slips on the beam walk test compared to those in the vehicle group (p = 0.041). MRI was used to measure the volumes of the whole brain, contralesional brain (hemisphere), and residual brain regions of interest, and the results indicated increased brain volume after the intravenous MSC infusions. The histological analyses revealed increased thicknesses of the contralesional cortex and corpus callosum in the MSC group compared with those in the vehicle group (p = 0.021, p = 0.019), which confirmed the volume increases. In the contralesional cortex, the MSC-treated group exhibited significant increases in the numbers of NeuN-positive cells (p = 0.004) and synaptic puncta (p = 0.000) compared with the numbers observed in the vehicle group.CONCLUSIONSThe intravenous infusion of MSCs resulted in improvements in functional outcome, increased brain volume, and enhanced synaptogenesis in HI rats.


2018 ◽  
Vol 5 (4) ◽  
pp. 2208-2222
Author(s):  
Alpana Dave ◽  
Srabani Kar ◽  
Ena Ray Banerjee

Introduction: Pulmonary Fibrosis is characterized by excessive matrix deposition which leads to airway remodeling and disruption of the typical architecture of the lung parenchyma. The disease progression is associated with a high mortality rate. The current treatment for pulmonary fibrosis includes drugs which either reduce progression of the disease or provide symptomatic relief. Multiple studies have examined the effect of cell-based therapy in pulmonary fibrosis. We investigated the effect of administration of pre-conditioned bone marrow-derived mesenchymal stem cells (BMMSC) in a mouse model of pulmonary fibrosis. Methods: Firstly, we examined the effect of pre-conditioning on the cells using cell-based assays. We found that pre-conditioning did not significantly alter cell proliferation or led to cellular inflammation. The cells continued to express MSC marker, CD105, and pluripotency marker Oct3/4. Next, we evaluated the proliferative and anti-inflammatory potential of BMMSC administration using a series of assays in a mouse model of pulmonary fibrosis. Bleomycin was administered to induce pulmonary fibrosis in mice on Day 0. MSCs were administered on day 1 and day 3; the mice were sacrificed on day 22, and their tissues were collected for analysis. Results: We found that similar to untreated cells, administration of pre-conditioned cells resulted in an increase in the proliferative potential and reduction in inflammation in the lung tissue, bronchoalveolar lavage, bone marrow, and blood. We observed reduction in the number of granulocytes in peripheral blood upon MSC administration. However, we did not observe any structural changes in the lung upon MSC administration. We found a small reduction in collagen content in the lung which was also seen upon staining with Masson's trichrome. Conclusion: These results demonstrate that pre-conditioned BM-MSC lead to improvement in the disease state through paracrine effects but pre-conditioning of cells for 24 hours does not significantly improve the beneficial effect of MSC administration.


2019 ◽  
Vol 2019 ◽  
pp. 1-11
Author(s):  
Xiuzhi Yang ◽  
Yu Wu ◽  
Jiqing Li ◽  
Wuliang Yin ◽  
Yang An ◽  
...  

To investigate how a back propagation neural network based on genetic algorithm (GA-BPNN) optimizes the low-intensity pulsed ultrasound (LIPUS) stimulation parameters to improve the bone marrow mesenchymal stem cells (BMSCs) viability further. The LIPUS parameters were set at various frequencies (0.6, 0.8, 1.0, and 1.2 MHz), voltages (5, 6, 7, and 8 V), and stimulation durations (3, 6, and 9 minutes). As only some discrete points can be set up in the experiments, the optimal LIPUS stimulation parameter may not be in the value of these settings. The GA-BPNN algorithm is used to optimize parameters of LIPUS to increase the BMSCs viability further. The BMSCs viability of the LIPUS-treated group was improved up to 19.57% (P<0.01). With the optimization via the GA-BPNN algorithm, the viability of BMSCs was further improved by about 5.36% (P<0.01) under the optimized condition of 6.92 V, 1.02 MHz, and 7.3 min. LIPUS is able to improve the BMSCs viability, which can be improved further by LIPUS with parameter optimization via GA-BPNN algorithm.


Sign in / Sign up

Export Citation Format

Share Document